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1. Introduction
In the last decades, poisonous animals have gained notoriety since their venoms (secreted or
injected) contain several of potentially useful bioactive substances (polypeptide toxins), which
are mostly codified by a single gene or, in the case of venom organic compounds, by a given
enzymatic route presented in a specialized tissue where the biosynthesis occur – the venom
gland.
In this context, in the age of genomic sciences, sequencing the entire genome or portion of it,
can be thought as the straightforward step to understand a given venom composition.
Particularly because, in many cases, the venom is produced in so small quantities, requiring
great challenge (natural and bureaucratic) to obtain biological material for its investigation or
the necessity of sacrifice the animal to get samples for analysis by conventional biochemical
methods. Genome sequencing allows us the identification of mRNAs, as well as prediction of
protein structure and function. In addition, the construction of cDNA libraries is useful to
clone, catalog and identify genes, and subsequently express the proteins of interest from these
libraries. By this approach, we can have adequate amounts of polypeptide toxins for functional
analysis and application, by which otherwise would be difficult to isolate.
According to [1], venoms’ complexity in terms of peptide and protein contents, together with
the number of venomous species indicate that only a small proportion (less than 1%) of the all
bioactive molecules has been identified and characterized to date, and little is known about
the genomic background of the venomous organisms. Consequently, if we take into account
that nature, operated by evolutionary processes, is the most efficient source of new functional
molecules and drug candidates, the study of all species of venomous animals, including small
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insects, such as those belonging to the order Hymenoptera [2] will be crucial and timely for
basic and applied research.
2. Ants biology: Subfamily Ponerinae
Ants (Vespoidea: Formicidae) belong to the insect order Hymenoptera, which includes other
important families like Apidae (bees) and Vespidae (wasps) [3]. The family Formicidae consists
of approximately 13.000 species of ants, most of them exibiting an advanced and sophisticated
social life. With colonies ranging from tens to millions of individuals, a high diversity as well
as numerical and biomass dominance in almost every habitat throughout the world, ants form
an important component of terrestrial biodiversity, especially in the Neotropical Region, where
about 30% of all known ant species are found [4,5]. All ant species possess eusocial habits, the
most conspicuous one being the reproductive division of labor, with one to many queens
specialized in reproduction, while the more and less sterile, and nonreproductive workers,
help the queen(s) reproduction, tending the brood and dealing with all other tasks of the colony
like food collection, nest repair, nest and/territory defense [6].
With more than 1000 species distributed in 28 genera, like Dinoponera and Paraponera, the
Ponerinae subfamily is a primitive group of ants mainly found in tropical habitats [4]. It is also
one the four major ant groups (Myrmicinae, Formicinae, Ponerinae and Dolichoderinae), all
characterized by high species diversity and widespread geographic distribution [4]. Dinopo‐
nera Roger, 1861 [7] is a strictly Neotropical genus with six known species [5] that are consid‐
ered the largest ants of the world (3-4 cm in length): D. australisEmery, 1910; D. gigantea(Perty,
1833); D. longipes Emery, 1901; D. lucidaEmery, 1901; D. muticaEmery, 1901; and D. quadriceps
Santschi, 1921 (Figure 1). Like in other ponerine ants, Dinoponera colonies have a poor social
organization, with small colonies that are queenless [9, 10]. Contrary to most ant species, all
workers of the Dinoponera colony are potential reproductives with functional spermatheca.
However, only one (sometimes more) worker mate and become the dominant worker with
reproductive function that is regularly disputed by subdominant workers [9, 10]. Like most
Ponerinae, Dinoponera are mostly predatory ants: their common prey are medium size to large
arthropods (mainly insects) that they subdue with their sting [11, 12]
Like all Aculeata hymenopterans (Chrysidoidea, Apoidea, Vespoidea), Dinoponera ants have
a sting apparatus that is located in the last portion of the gaster, and is formed by the sting
itself (derived from the ovipositor of more basal hymenopteran groups) along with two as‐
sociated glands: the Dufour’s gland and the venom gland [4,13]. In all ants, the venom gland
apparatus typically consists of paired venom secreting tubules that converge into a single
convoluted gland (an elongated continuation of the secretory tubule into the venom gland
reservoir), which in turn empties into a sac-like reservoir that leads into the sting (in ants
with sting) [4](Figure 2). In D. australis, it was shown that the convoluted gland has, like the
free tubules, a secretory function [14]. The free tubules and convoluted gland are responsible
for toxin production [14], which seems to be composed mainly of proteins [4,15]. Further‐
more, it was also shown that its morphology and ultrastructural organization presents simi‐
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larity with the convoluted gland of vespine waps (Vespinae), a fact that supports the
hypothesis of a phylogenetic origin of ants from wasp-like ancestors [14].
Figure 1. Dinoponera quadriceps (Quinet, Y.P. 2011)
Figure 2. Secretory apparatus from D. quadriceps (Quinet, Y.P. 2010)
In solitary Aculeata hymenopterans, and in social bees and wasps, the venom has two main
functions: prey capture and defense, respectively [13,16]. In ants, the products from the venom
exhibit much higher diversity of biological roles. Particularly In stinging ants, particularly in
primitive groups like Ponerinae, the primary function of venom gland products is to serve as
injectable offensive or/and defensive agents (to capture prey, fight with competitors or against
predators, for example) [13,16]. In more derived functions, the venom gland products are used
as defensive (toxic and/or repellent) agents by non-stinging ants that topically apply them on
the cuticle of enemies, as in Crematogaster or Monomorium ants for example. Venom gland
products can also serve as chemical communication agents (alarm and recruitment phero‐
mones, for example) [16,17].
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3. Clinical aspects of ants’ stings
Many insect stings are associated with local pathophysiological events, characterized by pain,
swelling and redness at the sting site for about 1-2 days [18]. The most severe reactions are
associated with allergic disorders, presenting neutrophilic and eosinophilic infiltration and
specific IgE production [19]. These manifestations are common in accidents with Hymenoptera
insects. Most studies that describe the clinical aspects of ant stings reported accidents with ants
of the genus Solenopsis (Myrmicinae), known as fire ants [20,21,22]. In most serious cases, these
accidental encounter with fire ants can promote multiple body rash, seizures, heart failure,
and serum sickness nephritis and, more rarely, acute renal failure [23,24].
Accidents with ants of the Ponerinae subfamily are rare or rarely reported. In fact, several
concomitant or sequential stings are necessary in order to produce significant clinical symp‐
toms of envenomation, in giant ants, multiple attacks are less probable, since workers have a
solitary foraging behavior. However, some of the accidents with giants ants may have medical
importance, such as the ones produced by the genus Paraponera and Dinoponera, popularly
known as “true tocandira” and “false tocandira”, respectively. Their stings are extremely
painful and can cause potentially systemic manifestations such as fever, cold sweats, nausea,
vomiting, lymphadenopathy and cardiac arrhythmias [8,25,26]. According to [27,28] the
venom of these ants may be neurotoxic for other insects.
4. Venom composition and pharmacological properties
The ant’s venoms have been investigated in a relatively small number of species. In the group
of stinging ants, the most investigated species belong to the Myrmeciinae, Ponerinae, Pseu‐
domyrmecinae and Myrmicinae subfamilies. They produce aqueous solutions of proteina‐
ceous venoms containing enzymatic and non-enzymatic proteins, free amino-acids and small
biologically active compounds like histamine, 5-hydroxytryptamine, acetylcholine, norepi‐
nephrine, and dopamine [16,17]. Venoms with proteinaceous components are considered as
most primitive and are consequently found in other aculeate hymenopterans like wasps and
bees [4,16]. A notable exception to this proteinaceous nature of the venom in ants with sting
is found in ants of the genera Solenopsis (fire ants) and Monomorium (Myrmicinae) that produce
alkaloid-rich venoms with few proteins. In the Formicinae ants (ex: Camponotus, Formica), the
sting is no more presented, but the poison gland produces a mixtures of simple organic acids
an aqueous solution. Formic acid is presented in concentrations up to 65% along with some
peptides and free amino-acids [16,17].
As a member of a group of predatory ants (Ponerinae), it is expected that Dinoponera would
produces such a kind of proteinaceous venom. However, until now few studies have been
done with Dinoponera venoms. In two of these studies, which compared venoms of a variety
of hymenopterans, the presence of proteins, some with enzyme activities (phospholipase A,
hyaluronidase, and lipase), was shown for D. grandis (in fact, D. gigantea) venom [16,29]. In a
more recent study, in which the peptide components from the venom of D. australis was
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investigated, over 75 unique protein components were found with a large diversity of
properties ranging in size, hydrophobicity, and overall abundance [30]. The biological effects
of several ants’ venoms have been attributed to their protein repertoire. As showed by [31]
high molecular weight proteins are present in the venom of Dinoponera australis. In a compa‐
rative evaluation of protein composition of hymenopteran venom reservoirs, proteins with
molecular weight ranging from 24 to 75kDa were evidenced [29]. Additionaly, two peptides
with less than 10 kDa, as well as proteins with molecular weight ranging from 26-90 kDa were
also found in the venom of Myrmecia pilosula [32]. The electrophoretic profile of wasps also
shows variation in the protein molecular weight, ranging from 5 to 200kDa [33,34], whereas
the venoms of bees was shown to range from 2 to108 kDa [35].
5. Pharmacology and therapeutic uses of venom form ants
The first reported case about the therapeutic use of venoms from ants were to treat rheumatoid
arthritis. In fact, insects might have components that justify its use in traditional medicine in
countries of East Asia, Africa and South America [36]. Lately, several studies of ant venom
aimed to demonstrate their beneficial intrinsic properties such as reduction of inflammation,
pain relief, improved function of the immune system and liver [37,38].
As the venom from Ponerinae subfamily is composed of a complex mixtures of proteins and
neurotoxins [39] we would expected to have several pharmacological properties. Small
peptides isolated from Paraponera clavata venom, called poneratoxin (PoTx) interfere with
sodium channels function and have potential use as a biological insecticide [40,41].
Several distinctive pharmacological activities were demonstrated with peptides isolated from
Pachycondyla goeldii and Myrmecia sp. In one of these works, antimicrobial activity against both
Gram positive and Gram negative bacteria was observed [42, 43]. In a recent study [44], it was
reported that the venom from Pachycondila sennaarensis has a significant antitumor effect on
breast cancer cells in a dose and time dependent manner without affecting the viability of non
tumor cells. In addition, some studies have also shown the renal effects of Hymenoptera
venoms. In fact, in more serious accidents with venoms from wasps and bees acute renal failure
generally occurs [45,46, 47, 48].
6. Genomic study of ant venom composition
Since the description of DNA double helix by Francis Crick and James Watson (1953), re‐
combinant DNA technology and genomics revolutionized numerous areas of life science. The
comprehension of the biochemical and molecular basis of inheritance had been improved our
knowledge about the complexity of all forms of life and the manner how genes and proteins
interact to create diversity. The genomic revolution was additionally expanded with the advent
of bioinformatic, the ‘omic’ science (transcriptomic, proteomic, peptidome, metabolomic,
glycome) and, presently, system biology.
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Collective efforts have been joined to annotate the gene composition of insects. The first
complete sequenced genome of insect was from the fruit fly Drosophila melanogaster, in 2000,
followed by a flurry of activities aimed at sequencing the genomes of several additional insect
species. In the field of toxinology, the hymenopterans are receiving special attention due to
their behavior and the ability to produce venom.
Up to now, at least 10 ant species had their genomes analyzed and published. The ants whose
genomes were sequenced include: the fire ant Solenopsis invicta found in South America, United
States, China, Taiwan, Australia [49]; the Argentine ant Linepithema humile [50], the leaf-cutting
ant Acromyrmex echinator [51] and Atta cephalote [52] found in South America; the red harvester
Pogonomyrmex barbatus found in North and South America [53], the florida carpenter ant
Camponotus floriandus from United States; and, the jumper ant Harpegnatos saltator from India,
Sri Lanka and Southeast Asia [54]. Those ant genomes have provided hundreds of new
available nucleotide data.
Apart of a detailed genome analysis, the construction of cDNA libraries from ants’ venom
glands is an important tool in order to analyze venom composition and discover new molecules
that could have biological and pharmacological properties. But an important question arises:
why hymenopteran venoms? As we pointed at the beginning of this chapter, there are several
reports that hymenopteran venom could have biological properties useful for medical purpos‐
es. In this scope, from traditional and modern medicine reports, description can be found not
only about clinical manifestation caused by hymenopterans venom, as allergic response, but al‐
so the benefits of ant venom to treat disease like rheumatoid arthritis and pain [36].
Genomic and transcriptomic studies of hymenopteran cDNA libraries would provide useful
information about their protein constituents. Some of these informations would include signal
peptide sequences and the presence of post-translational modifications, which cannot be
predicted by the studies of mature proteins. Ants genomic studies have shown a number of
substances involved in the biology of these insects, such as: vittelogenins, gustatory and
odorant receptors, molecules involved in immune response, as well as metabolic and structural
proteins like cytochrome P450.
7. Molecular pharmacology and toxinology of D. quadriceps venom
Recently, we have initiated a research project dedicated to investigate the composition, the
pharmacological properties, and the transcripts from the venom gland components of
Dinoponera quadriceps.
Using one-dimensional (SDS-PAGE) electrophoresis (1-DE) to resolve Dinoponera quadriceps
venom proteins, only eight major large polypeptides (ranging from 15 to 100 kDa) were
visualized by Comassie Brilliant Blue (CBB) Staining. The 1-DE and the insensitive method of
staining with CBB was not adequate to separate small proteins below 15 kDa and peptides
(Figure 3)
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Figure 3. Electrophoretic profile of Dinoponera quadriceps total venom (DQv) in one-dimensional SDS-PAGE gel elec‐
trophoresis visualized with Comassie Brilliant Blue.
The peptide mass fingerprint (PMF), as well as other proteomic analysis is being conducted
and a report will be published elsewhere.
Pharmacological studies have been realized with Dinoponera quadriceps venom, particularly,
in a system of isolated perfused rat kidney. We now know that at concentrations of approxi‐
mately 10μg/mL increased urinary flow, glomerular filtration rate and decreased vascular
resistance and sodium tubular transport, suggesting a natriuretic and diuretic effect. Further‐
more, in studies with renal tubule cells (MDCK - Madin-Darbin Canine Kidney) the same
venom induced cell cytotoxicity, on MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte‐
trazolium bromide) at a dose and time dependent manner. Interestingly, greater cytotoxicity
was observed in the shorter incubation periods, suggesting that the cell culture could recover
after a given exposure time. Additional assays have been designed to evaluate the biological
and pharmacological activity of purified component of this venom, as well as highlighting the
mechanisms related to the observed effects.

































































Figure 4. Effect of D. quadriceps total venom (DQv) on Urinary flow (UF; A), sodium tubular transport percent(%pTNa;
B) and renal vascular resistence (RVR; C). Ctrl=control. Results are expressed as means ± S.E.M., *p<0.05 (ANOVA).









































Figure 5. Citotoxicity of D. quadriceps total venom on MDCK (Madin-Darbin Canine Kidney) cells culture on MTT assay.
Results are expressed as means ± S.E.M., *p<0,05 (ANOVA).
Recently we also demonstrated the neuroprotective activity of D. quadriceps venom in models
of seizures induced by pentylenetetrazol (PTZ), when administered intraperitoneally. The
effect was an increase in latency to first seizure and a tendency to increased latency of death,
as well as reduction of lipid peroxidation in the prefrontal cortex of mice [55].
Figure 6. Effects of D. quadriceps venom (DQv) on latency of the first seizure in the models of seizure of pentylenete‐
trazol (PTZ) (A), pilocarpine (PILO) (B) and strychnine (STRC) (C). Results are expressed as means ± S.E.M., *p<0.05 (AN‐
OVA).
Figure 7. Effects of D. Quadriceps total venom (DQv) on latency of death in models of seizure of pentylenetetrazol
(PTZ) (A), pilocarpine (PILO) (B) and strychnine (STRC) (C). Results are expressed as means ± S.E.M (n=8), *p<0.05.
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A part of proteomic and pharmacological studies, we prepared a D. quadriceps venom gland
cDNA library to use an EST-strategy to identify the major transcripts expressed in the giant
ant venom.we successfully constructed a full-length cDNA library of approximately 20 venom
glands from D. quadriceps, using In-Fusion SMARTer kit (Clontech, USA). We obtained an
efficiency of 1x105 cfu/μg of DNA, our medium insert was 700bp and the library was amplified
and stored at -80°C. A total of 432 individual ESTs were sequenced by the dideoxy chain
termination (Sanger) method. Of these, 125 were undergone to a preliminary analysis through
BLASTx. The Tabel 1 and Figure 8(A) shows an overview of the relative abundance of the
protein groups.Most of the transcripts represent proteins involved in the whole metabolism
as transferases, ATP synthase, dehydrogenases, ribosomal proteins, cytocrome c. Those
sequences are being annotated for deposit in DNA and protein data bank. A note of caution
is that, as in most trancriptome project, a significant number of transcripts showed no simi‐
larities with well-known sequences in data bank. These ESTs presents a typical structure of
true ORFs (Open Reading Frame), that is start and stop codons, in addition a poly A tail. They
were classified as (1) hypothetical proteins with unknown function and (2) cDNA precursors
with no hits found. However, by comparing against DNA and protein data the hypothetical
proteins showed high similarities with proteins from scorpions (Opisthacanthus cayaporum) and
others ants, as Harpegnatos saltator, Solenopsis invicta and Camponotus floriandus. The Figure
8(B) represents the percentage of three classification of hits over the total clones analyzed, were
probable toxins comprises a significant percentage of ESTs, representing about 34% of
messages. Other 37% represents no-significant hits, which give us a number of perspectives
to analyze several novel proteins.
Class Function % Clones
No hit Typical ORF with no hits 40.8
DnTx Mast cell degranulation 28.8
Hypothetical protein Unknown function 12.0
Antigen like Allergenic 9.6
Cytocrome c oxidase Metabolism 1.6
Cytocrome b Metabolism 1.6
Transferase Metabolism 2.4
Ionic channel blocker Toxin 1.6
Ribossomal protein Structural protein 1.6
Chymotripsin inhibitor Metabolism 0.8
Dehydrogenase Metabolism 0.8
ATP synthase Metabolism 0.8
Phospholipase A1 Enzyme/Toxin 0.8
Bacterial ESTs Symbionts (?) 4.0
Mitocondrial protein Metabiolism 0.8
Table 1. Classification of ESTs from D. quadriceps venom gland cDNA library on their putative functions.
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 (a) (b) 
Figure 8. Classification of ESTs from D. quadriceps venom gland cDNA library on their putative functions (A). Relative
proportion of toxin-encoding, non-toxing encoding and no significant hit ESTs (B).
As a matter of example, the most abundant toxin was dinoponera toxin (DnTx). The dinopo‐
neratoxin whole sequence (accounting for 27% of the total clones analysed) was identified in
this cDNA library. Deduced aminoacid sequences (DnTx01 and DnTx02), corresponding to
two cDNA isoform precursos, from D. quadricipes transcriptome (this work) and three mature
venom peptides (DnTx_Da-3105, DnTx_Da-3177 and TX01_DINAS - GenBank accession
numbers GI:294863162, GI:294863159 and GI:294863158, respectively) from D. australis [30]
were aligned with ClustalW software using default parameters (http://www.ebi.ac.uk).
DnTx01 and DnTx02 are represented with their respective signal peptides and pro-peptides,
in which putative cleavage sites are shown in green and blue, respectively, according to SignalP
software (http://www.cbs.dtu.dk/services/SignalP) and proteomic data. In the alignment A is
clearly observed that DnTX01 shares high similarity with DnTx_Da-3105 and DnTx_Da-3177,
whereas the mature DnTx02 and TX01_DINAS are highly similar to each other (part B).
Figure 9. Alignment of dinoponeratoxin precursors and mature peptides from D. quadricipes and D. australis using
ClustalW software (http://www.ebi.ac.uk).




Taking into account the information presented in this chapter, a second question arises and
should be answered in the near future: “Is there any hymenopteran venom component that
could be used as a biotechnological tool?” The majority of works done to discovery new bio‐
technological tools from hymenopteran venoms were performed using proteomic science
analysis, probably because ants apparatus venom is so hard to identify and dissect. Never‐
theless, the size of some poneromorph primitive ants may permit subdue these difficulties
allowing us to construct a cDNA library and thus opening new perspectives to better under‐
stand the biology of ants as well as to analyze the properties of the venom in the search for
new molecules with pharmacological and / or biotechnological potential.
Thus, its clear that further work is necessary to understand ant venom, as well venoms from hy‐
menopteran, since several precursors comprises hypothetical and predicted toxins/polypepti‐
des with unknown function. Moreover, a deep functional analysis in the coming period will be
made to comprehend the effects presented by total venom and peptides isolated from it.
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